Embesin
*Company:
AOP Orphan Pharmaceuticals GmbHStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 14 February 2025
File name
Embesin PIL072023.pdf
Reasons for updating
- Change to section 6 - date of revision
Updated on 14 February 2025
File name
Embesin SPC012024.pdf
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 08 February 2022
File name
VASA2_IE_PIL_2021-Sep.pdf
Reasons for updating
- Change to section 6 - manufacturer
Updated on 19 July 2021
File name
IE_VAS_Embesin_SmPC_Feb_2021.pdf
Reasons for updating
- Change to section 6.3 - Shelf life
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Increased shelf life from 18 to 36 months
Updated on 16 January 2019
File name
IE_VAS_Embesin_PIL.pdf
Reasons for updating
- New PIL for new product
Updated on 05 December 2018
File name
IE_VAS_Embesin_SmPC.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
AOP Orphan Pharmaceuticals GmbH
Address:
AOP Orphan, Colmore Plaza, 20 Colmore Circus Queensway, Birmingham, B4 6AT.Medical Information E-mail:
medinfo@aoporphan.comTelephone:
+44(0) 121 262 4119Fax:
+44(0) 121 566 9010Website:
https://www.aop-health.com/global_enStock Availability:
+44(0) 121 262 4119 or office.ie@aoporphan.com